(Markets Insider) Strategists at JPMorgan believe investors can benefit from another 40% bull run in commodities, pointing out that the asset class is still under-allocated. The strategists say that commodity…
(Department of Labor) Jobless claims in the US in the week that ended April 2 was recorded at 166,000, a decline of 5,000 from the revised level of last week.…
(technode) China’s messaging app giant WeChat has said it has started supporting payments using a digital yuan in all of the 23 regions. The select regions are those where the…
(CDK Global) Shares of CDK Global Inc. rose more than 10% in premarket on Thursday after announcing an $8.3 billion acquisition by Brookfield Business Partners. CDK shareholders are set to…
(SEC) Shares of HP Inc. rose more than 14% on Wednesday in premarket after news emerged that Berkshire Hathaway bought $4.2 billion worth of shares in the company. The purchase…
(OpenSea) OpenSea has announced that Solana beta has officially entered the non-fungible token platform. The latest development means that OpenSea users can buy and sell Solana NFTs on the marketplace…
(FT) Facebook’s parent Meta plans to introduce virtual coins, tokens, and lending services that will be offered via its apps. Dubbed “Zuck Bucks,” the virtual currency reflects Meta’s push into…
(EIA) Total commercial crude oil inventories in the US were recorded at $412.4 million barrels in the week to April 1, reflecting an increase of 2.4 million from the previous…
(Reuters) America has placed Russian Sberbank under a total ban, including banning all US citizens from investing in Russia following what it believes to be war crimes in Ukraine. Energy…
(SEC) The ProShares Short Bitcoin Strategy ETF could be a potential new product in the market if it earns the approval of the US Securities & Exchange Commission. The new…
(MBA) The refinancing index for US home mortgages fell by 9.9% in the week to April 1 to reach 1,166.3 as the mortgage rates increased. The fall in refinancing was…
(BioXcel) Shares of BioXcel Therapeutics rose more than 24% in premarket on Tuesday after saying its treatment course for Bipolar I and II disorders in adults was approved by FDA.…